TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 172 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,512 | -82.7% | 281 | -70.3% | 0.00% | – |
| Q2 2023 | $14,516 | +4.1% | 945 | +52.4% | 0.00% | – |
| Q1 2023 | $13,944 | -13.4% | 620 | -19.1% | 0.00% | – |
| Q4 2022 | $16,109 | -15.2% | 766 | -1.3% | 0.00% | – |
| Q3 2022 | $19,000 | +5.6% | 776 | +3.2% | 0.00% | – |
| Q2 2022 | $18,000 | 0.0% | 752 | +5.9% | 0.00% | – |
| Q1 2022 | $18,000 | -18.2% | 710 | -0.1% | 0.00% | – |
| Q4 2021 | $22,000 | +29.4% | 711 | -1.7% | 0.00% | – |
| Q3 2021 | $17,000 | +750.0% | 723 | +343.6% | 0.00% | – |
| Q2 2021 | $2,000 | -50.0% | 163 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | 0.0% | 163 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | – | 163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deep Track Capital, LP | 7,370,000 | $113,203,200 | 5.24% |
| Finepoint Capital LP | 761,721 | $11,700,035 | 4.05% |
| Kynam Capital Management, LP | 1,454,730 | $22,344,653 | 3.07% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 441,019 | $6,769,642 | 2.06% |
| MPM BioImpact LLC | 552,846 | $8,491,715 | 1.71% |
| ARMISTICE CAPITAL, LLC | 7,450,000 | $114,432,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 435,313 | $6,686,408 | 1.12% |
| Octagon Capital Advisors LP | 495,000 | $7,603,200 | 1.06% |
| Orbimed Advisors | 2,118,100 | $32,534,016 | 0.59% |
| Rock Springs Capital Management LP | 1,527,720 | $23,465,779 | 0.56% |